Human trials of Vietnam’s homegrown COVID-19 vaccine suspended due to lack of unvaccinated volunteers
The third phase of human trials of the Covivac vaccine has been put on hold
The third phase of human trials of the Covivac vaccine has been put on hold
Covivac is expected to be distributed to the local market within the first quarter of 2022
Covivac, if the trial is successful, will sell for US$2.8 per dose
The human trial of Covivac will take place two months ahead of schedule